Viread, Tenofovir

Bookmark

Add to MyYahoo RSS

Viread, Tenofovir News

News on Viread, Tenofovir (generic) continually updated from thousands of sources around the net.

12 hrs ago | Seeking Alpha

Sovaldi's Q1 Is A Home Run With Men On Base; Why Gilead May Triple From Here

The company announced an in-line quarter for most of its products, but a monster one for its new product Sovaldi.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Hepatitis, Health, HIV/AIDS

Tue Apr 22, 2014

Customer Interaction Solutions

Research and Markets: Global HIV Therapeutics in Major Developed Markets to 2019

Thanks to patent expirations of several key therapies, the Human Immunodeficiency Virus treatment market value will increase at a slow pace in the coming years, from $14.3 billion in 2012 to $16.3 billion by 2019, at a Compound Annual Growth Rate of 1.9%.

Comment?

Related Topix: HIV/AIDS, Health, Medicine

Mon Apr 14, 2014

Seeking Alpha

Reevaluating Gilead Sciences After The Sell-Off

Background : On April 7, Seeking Alpha published an article I wrote on Gilead Sciences .

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Hepatitis, Health, Influenza, Tamiflu, Oseltamivir (generic), HIV/AIDS

Mon Mar 31, 2014

Aidsmap

HIV & AIDS Information :: Risk score can help predict which people living with HIV have highest risk of kidney disease during tenofovir treatment

Investigators in the United States have developed a risk score to predict which people living with HIV have the highest risk of developing chronic kidney disease.

Comment?

Related Topix: Medicine

Thu Mar 20, 2014

POZ

BMSa s Attachment Inhibitor Shows Promise

A promising trial of Bristol-Myers Squibb's investigational attachment inhibitor GS-663068 raises hope of the introduction of a new antiretroviral drug class, which would especially benefit those with multidrug resistance, aidsmap reports.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, HIV/AIDS, Health

•••
•••
•••
•••
•••
•••
•••
•••